Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Grace Therapeutics, Inc GRCE

Healthcare
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel... see more

NDAQ:GRCE - Post Discussion

Grace Therapeutics, Inc > CAPRE works better than VASCEPA but study was a bust
View:
Post by Rosmorduc on Sep 01, 2020 10:25am

CAPRE works better than VASCEPA but study was a bust

Management really screwed this up royally. 

Patients were put on a TLC and exercise regimen by doctors and placebo reduced TG almost as half as CAPRE. 

So when will Jan get the boot?
Comment by boozehound3 on Sep 01, 2020 12:14pm
It's over rosmorpuk   Take your losses and move on 
Comment by Rosmorduc on Sep 01, 2020 12:30pm
I have a position which used to be 5% of my portfolio and now 2%.  Not a big deal to hang around to see what happens. 
Comment by boozehound3 on Sep 01, 2020 12:43pm
Ha ha that's it.  1000 shares.  The way you pumped this I swear you had tons of shares
Comment by Rosmorduc on Sep 01, 2020 1:23pm
I had a lot more than a 1000 shares but oh well....
Grace Therapeutics, Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities